Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Xortx Therapeutics Inc (XRTX)

Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
XORTX Announces Closing of US$5 Million Public Offering GlobeNewswire - Tue May 19, 6:00AM CDT

CALGARY, Alberta , May 19, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Announces US$5 Million Public Offering GlobeNewswire - Thu May 14, 6:00AM CDT

CALGARY, Alberta, May 14, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Meets Nasdaq Continued Listing Requirements GlobeNewswire - Tue Apr 21, 6:00AM CDT

CALGARY, Alberta, April 21, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset GlobeNewswire - Mon Apr 13, 4:00PM CDT

• VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney disease • CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) --...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Confirms Effective Date of Share Consolidation GlobeNewswire - Wed Apr 1, 12:00PM CDT

CALGARY, Alberta, April 01, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Announces Results of Annual and Special Meeting of Shareholders GlobeNewswire - Thu Mar 26, 5:00PM CDT

CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Announces Change of Effective Date of Share Consolidation GlobeNewswire - Thu Mar 26, 3:32PM CDT

CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Announces Share Consolidation GlobeNewswire - Wed Mar 25, 5:15PM CDT

CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting GlobeNewswire - Tue Mar 24, 4:00PM CDT

CALGARY, Alberta, March 24, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders GlobeNewswire - Wed Mar 18, 6:00AM CDT

CALGARY, Alberta, March 18, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company...

XRTX.VN : 2.900 (+2.84%)
XRTX : 2.30 (+5.50%)

Barchart Exclusives

Intel Stock Has Risen Sixfold from Its 2025 Lows, but Don’t Expect a Dividend Yet Barchart - Tue Jun 9, 6:30PM CDT
INTC's reversal of fortunes has been a huge boon to investors, but with capex spending still expected to remain high and customers' cash slow to accumulate, don't expect Intel to reinstate its dividend anytime soon. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.